-
AML with Recurrent Abnormal Karyotypes
- -AML w/t(8;21)(q22;q22), AML1(CBFa/ETO)
- -AML w/ t(15:17)(q22;q12), (PML/RARa)
- -AML w/ inv (16)9p13q22) or t(16:16)(p12:q22), (CBLb/MYH11)
- -AML w/ 11q23 (MLL) abnormalities
-
AML with Multilineage dysplasia
AML with Multilineage dysplasia
-
AML as a Result of Previous Therapy
AML as a Result of Previous Therapy
-
AML Not Otherwise Categorized
FAB M0-M7 Except of M3
-
Acute Leukemia of Ambiguous Lineage
Acute Leukemia of Ambiguous Lineage
-
AML with Recurrent Abnormal Karyotypes
- AML w/t(8;21)(q22;q22), AML1(CBFa/ETO): Looks like AML with maturation, Myeloblasts, Auer Rods
- AML w/ t(15:17)(q22;q12), (PML/RARa): Acute promyelocytic leukemia
- AML w/ inv (16)9p13q22) or t(16:16)(p12:q22), (CBLb/MYH11): like acute myelomonocytic leukemia with immature, abnormal eosinophils in the marrow
- AML w/ 11q23 (MLL) abnormalities: Morphologically associated with monocyte abnormalities
|
|
